GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Pall Corporation (FRA:PA5) » Definitions » Debt-to-EBITDA

Pall (FRA:PA5) Debt-to-EBITDA : 2.46 (As of Apr. 2015)


View and export this data going back to . Start your Free Trial

What is Pall Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Pall's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2015 was €740 Mil. Pall's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2015 was €345 Mil. Pall's annualized EBITDA for the quarter that ended in Apr. 2015 was €442 Mil. Pall's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2015 was 2.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Pall's Debt-to-EBITDA or its related term are showing as below:

FRA:PA5' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0   Max: 2.28
Current: 2.28

During the past 13 years, the highest Debt-to-EBITDA Ratio of Pall was 2.28. The lowest was 0.00. And the median was 0.00.

FRA:PA5's Debt-to-EBITDA is not ranked
in the Industrial Products industry.
Industry Median: 1.75 vs FRA:PA5: 2.28

Pall Debt-to-EBITDA Historical Data

The historical data trend for Pall's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pall Debt-to-EBITDA Chart

Pall Annual Data
Trend Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 1.31 1.38 1.18 1.50

Pall Quarterly Data
Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.42 2.37 2.60 2.46

Competitive Comparison of Pall's Debt-to-EBITDA

For the Specialty Industrial Machinery subindustry, Pall's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pall's Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Pall's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pall's Debt-to-EBITDA falls into.



Pall Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Pall's Debt-to-EBITDA for the fiscal year that ended in Jul. 2014 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(379.032 + 277.735) / 437.634
=1.50

Pall's annualized Debt-to-EBITDA for the quarter that ended in Apr. 2015 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(739.895 + 345.088) / 441.892
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Apr. 2015) EBITDA data.


Pall  (FRA:PA5) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Pall Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pall's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pall (FRA:PA5) Business Description

Traded in Other Exchanges
N/A
Address
Pall Corporation is a New York corporation incorporated on July 31, 1946. The Company supplies filtration, separation and purification technologies. Its products are used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases. Its serves its customers through two businesses: Life Sciences and Industrial. The Life Sciences business group is engaged in developing, manufacturing and selling products to customers in the BioPharmaceutical, Food & Beverage and Medical markets. The Industrial business group is engaged in developing, manufacturing and selling products to customers in the Process Technologies, Aerospace and Microelectronics markets. The Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production, and are used in research laboratories, and the pharmaceutical and biotechnology industries. It also supplies products and technologies for food and beverage industries and in hospitals at the point of patient care. The Industrial segment provides enabling and process-enhancing technologies throughout the industrial marketplace. These include the Process Technologies, Aerospace and Microelectronics markets. It has the capability to provide customers with integrated solutions using its proprietary consumable filtration products for their process fluids. The Company's competition varies by product and application. Its competitors in the BioPharmaceuticals market include Merck Millipore (a division of Merck KGaA), The Sartorius Group and GE Healthcare (a unit of General Electric Company ("GE")). Its competitors in the Food & Beverage market include 3M Purification, Pentair, Inc., Filtrox Group, The Sartorius Group, Eaton Corporation and Parker Domnick Hunter (a division of Parker Hannifin). Its competitors in the Medical market include Merck Millipore, GE Healthcare, Teleflex Incorporated, Covidien plc and Intersurgical, Ltd. Its competitors in the Process Technologies market include CLARCOR Inc., Donaldson Company, Inc., Parker Hannifin Corporation, HYDAC International GmbH, GE Infrastructure (a unit of GE), Pentair, Inc., 3M Purification, U.S. Filter (a unit of Siemens AG) and ESCO Technologies Inc. Its competitors in the Aerospace market include Donaldson Company, Inc. and ESCO Technologies Inc. Its competitors in the Microelectronics market include Entegris, Inc., Parker Hannifin Corporation and Mott Corporation. The Company is subject to competition in all of the global markets in which it operates.

Pall (FRA:PA5) Headlines

No Headlines